0.5711USD-1.87%Mkt Cap: 3.39M USDP/E: 57.93Last update: 2026-05-26
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular dis…
Industry Peers
Drug Manufacturers - Specialty & Generic155.29BSEKP/E 172.0
58.11BTRYP/E 27.8
56.52BEURP/E 22.3
33.63BPLNP/E 21.9
24.50BUSDP/E 21.3
18.90BUSD—
15.76BUSDP/E 24.1
13.30BSEKP/E 40.0
Indicators:|
Key Statistics
Company
Market Cap3.39M USD
Enterprise Value3.62M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-11.72M USD
Revenue/Share—
Last Price0.5711 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)57.93
P/E (Forward)—
PEG—
EV/EBITDA-0.31
EV/Revenue—
P/S—
P/B0.54
EPS (TTM)0.01
EPS (Forward)—
52W Range
0.50001% of range6.200
52W High6.200 USD
52W Low0.5000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-519.94%
ROA-111.89%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.48M USD
CapEx (TTM)3.06M USD
FCF Margin—
FCF Yield35.22%
Net Debt-101.86K USD
Net Debt/EBITDA0.01
Balance Sheet
Debt/Equity0.10
Current Ratio0.06
Quick Ratio0.04
Book Value/Sh1.128 USD
Cash/Share0.0600 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateJun 16, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.5.85M
Float5.56M
Insiders0.94%
Institutions3.85%
Short Interest
Short Ratio0.2d
Short % Float2.12%
Short % Out.2.10%
Shares Short116.24K
Short (prev mo.)115.86K
Technical
SMA 500.8232 (-30.6%)
SMA 2002.081 (-72.6%)
Beta1.41
S&P 52W Chg28.31%
Avg Vol (30d)1.67M
Avg Vol (10d)298.27K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—